Abiopharma

Grifols Communication - Grifols to Hold Earnings Call for Q1 2026 Financial Results on May 7, 2026

Register of shareholders, changes and capital status – partial redemption – BONDS (Series 1)

SCHMID Introduces “Any Layer ET” Process for Full Panel-Level Advanced Packaging and Announces Speaking Engagement at ECTC 2026

Management and officers – staffing as of 30.4.26

WeRide to Report First Quarter 2026 Financial Results on Wednesday, May 13, 2026

Register of shareholders, changes and capital status – partial redemption of BONDS (series J and Yod-Aleph)

Appointment of external director – Vicky Eilon Baten, as of 26.4.26

FORM 10-K- Annual report which provides a comprehensive overview of the company for the past year

Additional proxy soliciting materials - definitive

Change in holdings of interested parties/officers - Amit Mor